article thumbnail

Who’s saying what? Big Data mentions in company filings of pharmaceutical industry decreased by 13% in Q1 2023

Pharmaceutical Technology

The global pharmaceutical industry experienced a 13% drop in company filings mentions of big data in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novartis with 185% year-on-year increase, according to GlobalData’s analysis of over 603 pharmaceutical company filings.

Big Data 147
article thumbnail

Who’s posting what? Big Data related social media posts increased by 11% in the pharma industry in Q1 2023

Pharmaceutical Technology

The global pharma industry experienced an 11% rise in social media posts on big data in Q1 2023 compared with the previous quarter, with the highest share accounted for Eli Lilly and Co, according to GlobalData’s analysis of social media posts. Buy the report here.

Big Data 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Pharmaceutical Trends Shaping the Future of Pharma Marketing in 2025

Pharma Marketing Network

With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. Big data analytics plays a crucial role in identifying prescribing patterns, understanding patient behaviors, and tailoring content strategies.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

article thumbnail

5 Top Emerging Pharmacovigilance Startups Impacting The Industry

Cloudbyz

Time is also of the essence in drug development, as competitive product-to-market lead times help pharma companies improve profitability. With the advancement in digital technologies, data collection from end-users enables pharma companies to take notice of certain trends.

article thumbnail

op Pharma Marketing Trends Shaping the Future of Healthcare in 2025

Pharma Marketing Network

Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users. As patients become more digitally savvy, pharma companies are investing in creating seamless digital experiences that cater to their needs and preferences.